Anna Karyn Lacy Whisler, - Medicare Clinical Social Worker in Logan, UT

Anna Karyn Lacy Whisler, is a medicare enrolled "Social Worker - Clinical" provider in Logan, Utah. She graduated from medical school in 2012 and has 12 years of diverse experience with area of expertise as Clinical Social Worker. She is a member of the group practice Family Solutions Counseling and her current practice location is 664 N Main St Ste 203, Logan, Utah. You can reach out to her office (for appointments etc.) via phone at (435) 915-6777.

Anna Karyn Lacy Whisler is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1184140345.

Contact Information

Anna Karyn Lacy Whisler,
664 N Main St Ste 203,
Logan, UT 84321-6204
(435) 915-6777
Not Available



Healthcare Provider's Profile

Full NameAnna Karyn Lacy Whisler
GenderFemale
SpecialityClinical Social Worker
Experience12 Years
Location664 N Main St Ste 203, Logan, Utah
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Anna Karyn Lacy Whisler graduated from medical school in 2012
  NPI Data:
  • NPI Number: 1184140345
  • Provider Enumeration Date: 08/19/2017
  • Last Update Date: 08/19/2017
  Medicare PECOS Information:
  • PECOS PAC ID: 1052651817
  • Enrollment ID: I20190314001579

Medical Identifiers

Medical identifiers for Anna Karyn Lacy Whisler such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1184140345NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1041C0700XSocial Worker - Clinical (* (Not Available))Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Family Solutions Counseling54961723897

News Archive

Ingenza celebrates success in securing EU H2020 SME Instrument support for SYNBIOMAN project

Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.

Spherix announces results of D-tagatose Phase 3 trial for Type 2 diabetes

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced results from its first Phase 3 trial post hoc analysis in which the higher body mass index (BMI) of the U.S. population relative to the Indian population was a likely key contributor to the more positive effects of D-tagatose in the lowering of HbA1c levels in the U.S. population. Initial results were announced on October 7.

BMS amends and extends MJN common stock exchange offer

Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).

Kraton Polymers' Cariflex polyisoprene products to be showcased at MEDTEC Europe

Kraton Performance Polymers, Inc., a leading global producer of styrenic block copolymers and other engineered polymers, announces plans to showcase Cariflex polyisoprene products, the pure and clean alternative to natural rubber for high performance medical applications, at MEDTEC Europe in Stuttgart, Germany.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Anna Karyn Lacy Whisler allows following entities to bill medicare on her behalf.
Entity NameIhc Health Services Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942325154
PECOS PAC ID: 1850209420
Enrollment ID: O20080610000303

News Archive

Ingenza celebrates success in securing EU H2020 SME Instrument support for SYNBIOMAN project

Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.

Spherix announces results of D-tagatose Phase 3 trial for Type 2 diabetes

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced results from its first Phase 3 trial post hoc analysis in which the higher body mass index (BMI) of the U.S. population relative to the Indian population was a likely key contributor to the more positive effects of D-tagatose in the lowering of HbA1c levels in the U.S. population. Initial results were announced on October 7.

BMS amends and extends MJN common stock exchange offer

Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).

Kraton Polymers' Cariflex polyisoprene products to be showcased at MEDTEC Europe

Kraton Performance Polymers, Inc., a leading global producer of styrenic block copolymers and other engineered polymers, announces plans to showcase Cariflex polyisoprene products, the pure and clean alternative to natural rubber for high performance medical applications, at MEDTEC Europe in Stuttgart, Germany.

Read more Medical News

› Verified 3 days ago

Entity NameFamily Solutions Counseling
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073034823
PECOS PAC ID: 5496172389
Enrollment ID: O20200824001193

News Archive

Ingenza celebrates success in securing EU H2020 SME Instrument support for SYNBIOMAN project

Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.

Spherix announces results of D-tagatose Phase 3 trial for Type 2 diabetes

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced results from its first Phase 3 trial post hoc analysis in which the higher body mass index (BMI) of the U.S. population relative to the Indian population was a likely key contributor to the more positive effects of D-tagatose in the lowering of HbA1c levels in the U.S. population. Initial results were announced on October 7.

BMS amends and extends MJN common stock exchange offer

Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).

Kraton Polymers' Cariflex polyisoprene products to be showcased at MEDTEC Europe

Kraton Performance Polymers, Inc., a leading global producer of styrenic block copolymers and other engineered polymers, announces plans to showcase Cariflex polyisoprene products, the pure and clean alternative to natural rubber for high performance medical applications, at MEDTEC Europe in Stuttgart, Germany.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Anna Karyn Lacy Whisler is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Anna Karyn Lacy Whisler,
523 N 750 E,
Hyde Park, UT 84318-3357

Ph: (435) 915-6777
Anna Karyn Lacy Whisler,
664 N Main St Ste 203,
Logan, UT 84321-6204

Ph: (435) 915-6777

News Archive

Ingenza celebrates success in securing EU H2020 SME Instrument support for SYNBIOMAN project

Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform. Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million.

Spherix announces results of D-tagatose Phase 3 trial for Type 2 diabetes

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced results from its first Phase 3 trial post hoc analysis in which the higher body mass index (BMI) of the U.S. population relative to the Indian population was a likely key contributor to the more positive effects of D-tagatose in the lowering of HbA1c levels in the U.S. population. Initial results were announced on October 7.

BMS amends and extends MJN common stock exchange offer

Bristol-Myers Squibb Company and Mead Johnson Nutrition Company today announced that Bristol-Myers Squibb Company ("BMS") has amended and extended its offer to exchange up to 170.0 million shares of common stock of Mead Johnson Nutrition Company ("MJN") for outstanding shares of BMS common stock that are validly tendered and not validly withdrawn at an exchange ratio determined by a formula described in a registration statement filed by MJN on Form S-4 (Reg No. 333-163126).

Kraton Polymers' Cariflex polyisoprene products to be showcased at MEDTEC Europe

Kraton Performance Polymers, Inc., a leading global producer of styrenic block copolymers and other engineered polymers, announces plans to showcase Cariflex polyisoprene products, the pure and clean alternative to natural rubber for high performance medical applications, at MEDTEC Europe in Stuttgart, Germany.

Read more News

› Verified 3 days ago


Social Worker in Logan, UT

Mr. Jared M. Taylor, LCSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 175 W 1400 N, Suite A, Logan, UT 84341
Phone: 435-752-5302    Fax: 435-753-9007
Ashley Carolina Brog, CSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 255 S Main St Ste 100, Logan, UT 84321
Phone: 801-822-2109    
Mr. Jeremy Clayton Hilton I, LCSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 246 E 1260 N, Logan, UT 84341
Phone: 435-750-6300    
Lorii Ann Hubbard, LCSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 2616 Black Walnut Dr, Logan, UT 84341
Phone: 435-890-9323    
Tia Lynn Rowley, CSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 150 E 200 N Ste O, Logan, UT 84321
Phone: 435-915-6777    
Megan Lynn Andersen, CSW, CTRS
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 40 W Cache Valley Blvd Ste 5c, Logan, UT 84341
Phone: 435-538-2152    
Jasmine Karinne Hopkins, LCSW
Clinical Social Worker
Medicare: Not Enrolled in Medicare
Practice Location: 2072 N Main St Ste 201, Logan, UT 84341
Phone: 801-655-5450    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.